Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07469670 · ClinicalTrials.gov registry record

Nasal Swab Objective and Statistical Evaluation (NOSE Study)

A clinical trial of SARS Coronavirus 2 RT-PCR Testing, sponsored by VA Office of Research and Development.

Completed
Registry status
1,179
Enrollment target
1
Study location

NCT07469670 is a study of SARS Coronavirus 2 RT-PCR Testing that has completed, run by VA Office of Research and Development. The registered enrollment target is 1,179 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07469670, a study of SARS Coronavirus 2 RT-PCR Testing, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
1,179 participants
Enrollment target
1
Study location

Study Summary

Supply chain disruptions have led to shortages in test swabs which are used to collect respiratory samples. Lack of these test swabs can reduce a hospital or state's ability to test patients for COVID-19. To address this shortage, many manufacturers, hospitals and individuals have designed non-traditional 3D printed swabs for COVID-19 diagnosis that could potentially meet demands for nasal swabs. However, questions regarding the safety and effectiveness of these swabs remain. This study will provide additional, statistically supported evidence as to the safety and efficacy of novel swabs.

Study Locations (1)

Washington

  • VA Puget Sound Health Care System Seattle Division, Seattle, WA - Seattle

Trial Details

FieldValue
Enrollment Target 1,179 participants
Start Date 2021-04-05
Est. Completion 2022-08-16

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT07469670

The ClinicalTrials.gov registry entry for NCT07469670 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,179 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with SARS Coronavirus 2 RT-PCR Testing appearing as the primary indexed condition, and to 0 interventions.

NCT07469670 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT07469670 about?

NCT07469670 is a clinical study titled "Nasal Swab Objective and Statistical Evaluation (NOSE Study)". Supply chain disruptions have led to shortages in test swabs which are used to collect respiratory samples. Lack of these test swabs can reduce a hospital or state's ability to test patients for COVID-19. To address this shortage, many manufacturers, hospitals and individuals have designed non-trad...

What is the current status of trial NCT07469670?

This trial is currently completed. The enrollment target is 1,179 participants. The study started on 2021-04-05. Estimated completion is 2022-08-16.

What conditions does trial NCT07469670 study?

This clinical trial studies the following conditions: SARS Coronavirus 2 RT-PCR Testing.

Who is sponsoring clinical trial NCT07469670?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07469670 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.